The clinical utility of induced sputum for the diagnosis of bacterial community-acquired pneumonia in HIV-infected patients: A prospective cross-sectional study

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 2, 2006, Pages 89-93

  da Silva, Rosemeri Maurici ^a,c   Zimermann Teixeira, Paulo José ^b   da Silva Moreira, José ^b  

^a South University of Santa Catarina (UNISUL)   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c NONE   (Brazil)

Author keywords

Bacterial pneumonia; HIV; Induced sputum

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BRAZIL; CAUCASIAN; CLINICAL TRIAL; COLONY FORMING UNIT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GRAM STAINING; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG LAVAGE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; QUANTITATIVE DIAGNOSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION; TRANSBRONCHIAL BIOPSY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 33746908206     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Davis L., Beck J.M., Shellito J. Update: HIV infection and pulmonary host defenses. Semin Respir Infect 1993;8:75-85.
2. Haramati L.B., Jenny-Avital E.R. Approach to the diagnosis of pulmonary disease in patients infected with the human immunodeficiency virus. J Thorac Imaging 1998;13:247-60.
3. Barreto S.M., Molinari J.F. I Consenso brasileiro sobre pneumonias: pneumonias em portadores da Síndrome da Imunodeficiência Adquirida (SIDA/AIDS). J Pneumol 1998;24:95-100.
4. Murray J.F., Mills J. Pulmonary infectious complications of human immunodeficiency virus infection (Part I). Am Rev Respir Dis 1990;141:1356-72.
5. Murray J.F., Mills J. Pulmonary infectious complications of human immunodeficiency virus infection (Part II). Am Rev Respir Dis 1990;141:1582-98.
6. Skerret J.S. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999;20:531-48.
7. Speich R. Diagnosis of pulmonary problems in HIV-infected patients. Monaldi Arch Chest Dis 1993;48:221-32.
8. Cohn D.L., Stover D.E., O'Brien R.F., et al. Pulmonary complications of AIDS: advances in diagnosis and treatment. Am Rev Respir Dis 1998;138:1051-2.
9. Pitchenik A.E., Ganjei P., Torres A., et al. Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986;133:226-9.
10. Bigby T.D., Margolskee D., Curtis J.L., et al. The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986;133:515-8.
11. Conde M.B., Soares S.L., Mello F.C., et al. Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. Am J Respir Crit Care Med 2000;162:2238-40.
12. Gold J.A., Rom W.N., Harkin T.J. Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest 2002;121:1471-7.
13. Gracia J.D., Miravittles M., Mayordomo C., et al. Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients. Chest 1997;111:1180-6.
14. Mendelson J. Principles of neoplasia. In: Harrison TR, ed. Principles of internal medicine. 2a ed. New York:McGraw-Hill; 1991.p. 1576-87.
15. O'Dell M.W., Lubeck D.P., O'Driscoll P., Matsuno S. Validity of the Karnofsky performance status in an HIV-infected sample. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:350-7.
16. Gundy K.V. Boylen C.T. Fiberoptic bronchoscopy. Indications, complications, contraindications. Postgrad Med 1988;83:289-94.
17. Efthimiadis A., Pizzichini E., Pizzichini M.M.M., Hargreave F.E. Sputum examination for indices of airway inflammation: laboratory procedures. Canadian Thoracic Society 1997.
18. Petrillo V.F. A relevância clínica na preparação artesanal do esfregaço do escarro (judiciosamente selecionado) na bacteriologia dessa secreção: estudo comparativo com o aspirado de punção pulmonar transcutânea [Dissertação de Mestrado]. Porto Alegre: Universidade Federal do Rio Grande do Sul, 1987.
19. Marshall J.R. Manual de laboratório clínico-microbiologia. 1a ed. São Paulo: Santos Livraria Editora; 1995.
20. Luna L.G. Manual of histologic staining methods the armed forces institute of pathology. 3a ed. New York: McGraw-Hill Book Co New York; 1968.
21. Behmer O.A., Tolosa E.M.C., Neto A.G.F. Manual de técnicas para histologia normal e patológica. 1a ed. São Paulo: EDART; 1976.
22. Cordero E., Pachon J., Rivero A., et al. Usefulness of sputum culture for diagnosis of bacterial pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002;21:362-7.
23. Baughman R.P., Dohn M.N. Immunocompromised host. In: Baughman RP, ed. Bronchoalveolar lavage. St. Louis: Mosby Year Book Inc; 1992. p. 41-63.
24. Dawson-Saunders B., Trapp R.G. Basic and clinical biostatistics. Connecticut: Appleton & Lange; 1990.
25. Fletcher R.H., Fletcher S.W., Wagner E.H. Epidemiologia clínica. Bases científicas da conduta médica. 2a ed. Porto Alegre: Artes Médicas; 1989.
26. Menezes A.M.B., Santos I.S. Curso de epidemiologia básica para pneumologistas. 4a parte - epidemiologia clínica. J Pneumol 1999;25:321-6.
27. Gordon D.F., Jong B.B. Indigenous flora from human saliva. Applied Microbiology 1968;16:428-9.
28. Epstein M.R.L. Constituents of sputum: a simple method. Ann Intern Med 1972;77:259-65.
29. Baselski V., Mason K. Pneumonia in the immunocompromised host: the role of bronchoscopy and newer diagnostic techniques. Sem Respir Infect 2000;15:144-61.
30. Chuard C., Fracheboud D., Regamey C. Effect of sputum induction by hypertonic saline on specimen quality. Diagn Microbiol Infect Dis 2001;39:211-4.
31. Lode H., Schaberg T., Raffenberg M., Mauch H. Diagnostic problems in lower respiratory tract infections. J Antimicrob Chemother 1993;32 Suppl A:29-37.
32. Pirali F., Longo M., Gelmi M., et al. Diagnosis of bronchopulmonary infections by quantification of microflora. Eur J Epidemiol 1994;10:703-6.
33. Rimland D., Navin T.R., Lennox J.L., et al. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002;16:85-95.
34. Weinberg A., Duarte M.I.S. Respiratory complications in Brazilian patients infected with human immunodeficiency virus. Rev Inst Med Trop São Paulo 1993;35:129-39.
35. Danés C., González-Martín J., Pumarola T., et al. Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol. J Clin Microbiol 2002;40:2134-40.
36. Thorsteinsson S.B., Musher D.M., Fagan T. The diagnostic value of sputum culture in acute pneumonia. JAMA 1975;233:894-5.
37. Lentino J.R., Lucks D.A. Nonvalue of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol 1987;25:758-62.
38. Kvale P.A., Hansen N.I., Markowitz N., et al. Routine analysis of induced sputum is not an effective strategy for screening persons infected with human immunodeficiency virus for Mycobacterium tuberculosis or Pneumocystis carinii. Clin Infect Dis 1994;19:410-6.